AI Maverick Intel, Inc. Announces New Trading Symbol “AIMV” Effective Oct. 20, 2025
AI Maverick Intel (OTC:AIMV) announced that effective Oct. 20, 2025 its common shares will trade under the new ticker AIMV following the company's rebranding from Bionoid Pharma to AI Maverick Intel.
The change aligns the market identity with the company's strategic focus on AI-driven customer acquisition, partner-led deal flow, and revenue acceleration via its AI Maverick platform. The company said its CUSIP and corporate structure remain unchanged and shareholders are not required to take any action. Management expects to finalize strategic JV initiatives in Q4 2025 to broaden commercialization and accelerate customer acquisition.
AI Maverick Intel (OTC:AIMV) ha annunciato che a decorrere dal 20 ottobre 2025 le sue azioni ordinarie verranno negoziate sotto il nuovo ticker AIMV a seguito del rebranding dell'azienda da Bionoid Pharma a AI Maverick Intel.
Il cambiamento allinea l'identità di mercato con l'obiettivo strategico dell'azienda di acquisizione clienti guidata dall'IA, flusso di accordi guidato dai partner e accelerazione dei ricavi tramite la sua piattaforma AI Maverick. L'azienda ha dichiarato che il CUSIP e la struttura societaria rimangono invariate e che gli azionisti non sono tenuti ad alcuna azione. La direzione prevede di finalizzare iniziative strategiche di JV nel Q4 2025 per ampliare la commercializzazione e accelerare l'acquisizione di clienti.
AI Maverick Intel (OTC:AIMV) anunció que a partir del 20 de octubre de 2025 sus acciones comunes se negociarán bajo el nuevo ticker AIMV tras el cambio de marca de la empresa de Bionoid Pharma a AI Maverick Intel.
El cambio alinea la identidad de mercado con el enfoque estratégico de la empresa en adquisición de clientes impulsada por IA, flujo de acuerdos liderado por socios y aceleración de ingresos a través de su plataforma AI Maverick. La empresa dijo que su CUSIP y estructura corporativa permanecen sin cambios y los accionistas no están obligados a tomar ninguna acción. La dirección prevé finalizar iniciativas estratégicas de JV en Q4 2025 para ampliar la comercialización y acelerar la adquisición de clientes.
AI Maverick Intel (OTC:AIMV)는 2025년 10월 20일부터 보통주가 새 시세 기호 AIMV로 거래될 것이며 Bionoid Pharma에서 AI Maverick Intel로의 리브랜딩에 따른 것이라고 발표했습니다.
이 변화는 시장 정체성을 회사의 AI 주도 고객 확보, 파트너 주도 거래 흐름, 및 AI Maverick 플랫폼을 통한 수익 가속화에 대한 전략적 중점과 맞춥니다. 회사는 CUSIP 및 기업 구조는 변경되지 않으며 주주가 어떤 조치도 취할 필요가 없다고 말했습니다. 경영진은 상업화를 확대하고 고객 확보를 가속화하기 위해 2025년 4분기에 전략적 JV 이니셔티브를 마무리할 것으로 기대합니다.
AI Maverick Intel (OTC:AIMV) a annoncé que, à compter du 20 octobre 2025, ses actions ordinaires seront négociées sous le nouveau ticker AIMV à la suite du rebranding de la société de Bionoid Pharma à AI Maverick Intel.
Ce changement aligne l'identité du marché avec l'orientation stratégique de l'entreprise sur l'acquisition de clients pilotée par l'IA, le flux d'accords dirigé par les partenaires et l'accélération des revenus via sa plateforme AI Maverick. La société a déclaré que le CUSIP et la structure corporative restent inchangés et que les actionnaires ne sont pas tenus d'agir. La direction prévoit de finaliser des initiatives JV stratégiques au Q4 2025 pour élargir la commercialisation et accélérer l'acquisition de clients.
AI Maverick Intel (OTC:AIMV) gab bekannt, dass ab dem 20. Oktober 2025 seine Stammaktien unter dem neuen Ticker AIMV gehandelt werden, nach der Umfirmierung von Bionoid Pharma zu AI Maverick Intel.
Die Änderung schafft eine Marktidentität, die mit dem strategischen Fokus des Unternehmens auf KI-gesteuerte Kundengewinnung, partnergeführte Transaktionsströme und Umsatzbeschleunigung über die AI Maverick-Plattform übereinstimmt. Das Unternehmen erklärte, dass CUSIP und Unternehmensstruktur unverändert bleiben und die Aktionäre keinen Handlungsbedarf haben. Das Management rechnet damit, bis Q4 2025 strategische JV-Initiativen abzuschließen, um die Kommerzialisierung zu erweitern und die Kundengewinnung zu beschleunigen.
AI Maverick Intel (OTC:AIMV) أعلنت أنه اعتبارًا من 20 أكتوبر 2025 ستتداول أسهمها العادية بالرمز الجديد AIMV وذلك عقب إعادة العلامة التجارية للشركة من Bionoid Pharma إلى AI Maverick Intel.
يتماشى هذا التغيير مع الهوية السوقية من خلال تركيز الشركة الاستراتيجي على الاستحواذ على العملاء المدعوم بالذكاء الاصطناعي، وتدفق الصفقات بقيادة الشركاء، وتسريع الإيرادات عبر منصة AI Maverick. قالت الشركة إن CUSIP والهيكل المؤسسي يظلان دون تغيير وأن المساهمين غير مطلوب منهم اتخاذ أي إجراء. وتتوقع الإدارة إنهاء مبادرات JV الاستراتيجية في الربع الرابع 2025 لتوسيع التسويق وتسريع اكتساب العملاء.
AI Maverick Intel (OTC:AIMV) 宣布，自 2025年10月20日 起，其普通股将使用新股票代码 AIMV 进行交易，此前公司已将品牌从 Bionoid Pharma 重塑为 AI Maverick Intel。
这一变动使市场身份与公司在 AI 驱动的客户获取、合作伙伴主导的交易流以及通过其 AI Maverick 平台实现收入加速方面的战略重点保持一致。公司表示其 CUSIP 编码及公司结构保持不变，股东无需采取任何行动。管理层预计在 2025 第四季度 完成战略合资企业计划，以扩大商业化并加速客户获取。
- None.
- None.
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- via IBN – AI Maverick Intel Inc. (OTC: AIMV), a technology-driven innovator focused on redefining how businesses acquire and engage customers through artificial intelligence, today announced that effective Oct. 20, 2025, the Company’s common shares will commence trading on the OTC Market under its new ticker symbol “AIMV.”
This change follows the Company’s previously announced rebranding from Bionoid Pharma, Inc. to AI Maverick Intel, Inc., reflecting its strategic focus on partnering with companies to drive customer acquisition, close deals, and scale revenue with its AI Maverick platform. The new symbol aligns the Company’s market identity with its operational direction and innovation-focused mission.
“This marks another milestone in completing our transition to AI Maverick Intel,” said Wayne Cockburn, CEO. “The new ticker better represents who we are and where we’re headed as an AI-powered platform company focused on intelligent growth through customer acquisition, partner-led deal flow, and revenue acceleration.”
“Looking ahead to Q4, the Company expects to finalize strategic JV initiatives designed to leverage its core AI Maverick technology to accelerate customer acquisition, broaden partner commercialization, and drive sustainable revenue growth.”
The Company’s CUSIP number and corporate structure remain unchanged. Shareholders are not required to take any action in connection with the symbol change.
About AI Maverick Intel, Inc.
AI Maverick Intel, Inc. is an AI-powered growth company focused on driving customer acquisition and partner-led commercialization through its proprietary AI Maverick platform. The technology enables intelligent, two-way communication and data-driven engagement across industries. AI Maverick Intel aims to deliver long-term value through innovation, efficiency, and strategic partnerships.
For more information, visit www.aimaverickintel.com.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Stay Connected
Website | www.aimaverickintel.com | OTC: AIMV | X: @AIMaverickIntel
Media Contact
Wayne Cockburn, CEO
(905) 505‑0770
Email: maverick@aimaverickintel.com
SOURCE: AI Maverick Intel, Inc.
Corporate Communications
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com
FAQ
When will AI Maverick Intel start trading under the new ticker AIMV?
Do shareholders need to take any action for the AIMV ticker change?
Does the AIMV symbol change affect AI Maverick Intel's CUSIP or corporate structure?
What is the strategic reason for AI Maverick Intel changing its ticker to AIMV?
What near-term initiatives did AI Maverick Intel cite after the ticker change?
Will the AIMV ticker change affect how investors access company shares on the OTC market?
